Skip to Content
Søg Menu

Late Breaking: Patients with Advanced Biliary Tract Cancer Can Safely be Treated with Antibiotics and Continue Treatment with ICI

People with advanced biliary tract cancer can safely be treated with antibiotics, while still benefiting from treatment with durvalumab plus chemotherapy.

Få adgang

Hvis du er læge, sygeplejerske eller anden sundhedsprofessionel kan du få adgang til hele artiklen ved at oprette en profil på BestPractice Nordic.

Relateret indhold

Laurids Poulsen

ASCO GI 2023 om colorektalcancer – I et dansk perspektiv

/ Laurids Østergaard Poulsen
ASCOGI23 Play the Video 07:16
Wungki Park

First-Line Treatment of Claudin 18.2-Positive Metastatic Pancreatic Cancer with Zolbetuximab, Gemcitabine, and Nab-Paclitaxel

/ Wungki Park
ASCOGI23Pancreascancer Play the Video 4:43
Wungki Park

New potential standard-of-care for patients with CLDN18.2+/HER2- LA unresectable or mG/GEJ adenocarcinoma – an international perspective

/ Wungki Park
ASCOGI23HER2 Play the Video 3:18
Ken Kato

New option for 1. line treatment of advanced oesophagal squamous cell carcinoma – 29. Month Follow-up

/ Ken Kato
ASCOGI23Esofaguscancer Play the Video 11:05
Kohei Shitara

Promising Effect of Zolbetuximab and mFOLFOX6 Combination For Gastroesophageal Junction Adenocarcinoma

/ Kohei Shitara
ASCOGI23EsofaguscancerVentrikelcancer Play the Video 8:04
Stacey Cohen

No significant impact of plasma cfDNA levels on ctDNA detection rates across different MRD in patients with colorectal cancer

/ Stacey Cohen
ASCOGI23Colorektalcancer Play the Video 6:59
Laura Dawson

Positive effect of stereotactic body radiation therapy (SBRT) followed by sorafenib in patients with hepatocellular carcinoma

/ Laura Dawson
ASCOGI23Levercancer Play the Video 9:01
Josep Tabernero

New treatment option for refractory metastatic colorectal cancer – trifluridine/tipiracil plus bevacizumab

/ Josep Tabernero
ASCOGI23Colorektalcancer Play the Video 10:04

Late Breaking: Zolbetuximab + Chemo as New Potential Standard Treatment for Patients with Unresectable, Metastatic Gastric, or Gastro-Esophageal Junction Adenocarcinoma

/ BestPractice Nordic
ASCOGI23EsofaguscancerGastrointestinal cancerVentrikelcancer

Brænder du for at skrive?

Vil du gerne dele din forskning eller dine kliniske erfaringer med dine kollegaer inden for netop dit speciale? Har du en ide til en artikel, som du gerne vil udgive hos os? Send redaktionen en mail på redaktion@bpno.dk

Send mail til redaktionen
Back to top